Israel’s Teva buys Allergan generic drug company for $40.5B
Permalink

Israel’s Teva buys Allergan generic drug company for $40.5B

In a deal which had been anticipated, Teva Pharmaceutical Industries (NYSE: TEVA) announced it would…

Continue Reading →